Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and [Beta]-Cell Dysfunction in Humans

著录项

• 来源
  《Diabetes》 |2011年第3期|p.918-924|共7页
• 作者

  Changting Xiao Adria Giacca Gary F Lewis;

  展开▼
• 作者单位

  From the Departments of Medicine and Physiology, LIniversity of Toronto, Toronto, Ontario, Canada.Corresponding author Gary F. Lewis, gary.lewis@uhn.on.ca.Received 8 October 2010 and accepted 12 December 2010.DOI: 10.2337/dbl0-1433. Clinical trial reg. no. NCT00533559, clinicaltriaLs.gov.© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecomnions.org/licenses/by -nc-nd/3.0/ for details.;

  展开▼
• 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词